AstraZeneca's Evusheld vials. — Photo courtesy of the company
HANOI (Vietnam News/Asia News Network): A private hospital system in Vietnam said on Thursday (March 10) they are set to soon use AstraZeneca's Evusheld, a long-acting antibody combination (tixagevimab co-packaged with cilgavimab), for the prevention of Covid-19 for the most at-risk groups of the population.
Tâm Anh General Hospital system, via the Vietnam Vaccine Company (who also secured the first contract for AstraZeneca Covid-19 vaccines for Việt Nam in early 2021), will be the first to be given the green light from health authorities to use the treatment on their patients – starting with facilities in Hanoi and HCM City.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
